Skip to content

Establishment of an intelligent diagnosis system for primary liver cancer (HCC, ICC and cHCC-CCA) based on LIRADS

Establishment of an intelligent diagnosis system for primary liver cancer (HCC, ICC and cHCC-CCA) based on LIRADS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052789
Enrollment
Unknown
Registered
2021-11-05
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary liver cancer

Interventions

case series:none

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with suspected primary liver cancer who have not received any treatment before surgery (segment resection or liver transplantation); 2. MR examination is performed before operation, and the examination sequence is in accordance with the conventional scanning sequence; 3. The interval between surgery and MRI should not exceed 14 days; 4. The image quality of all MRI sequences reaches the diagnostic standard.

Exclusion criteria

Exclusion criteria: 1. Patients who have been diagnosed with liver cancer; 2. Patients who are allergic to magnetic resonance contrast agents; 3. Any other malignant tumor was diagnosed before treatment; 4. According to the judgment of the investigator, there are concomitant diseases that seriously endanger the safety of the subjects, may confuse the research results, or affect the subjects to complete the study (such as uncontrolled high blood pressure, severe diabetes, neurological or psychiatric disease, etc.) or any other condition.

Design outcomes

Primary

MeasureTime frame
tumor recurrence;

Secondary

MeasureTime frame
patient died;

Countries

China

Contacts

Public ContactYang Chun
yang.chun1@zs-hospital.sh.cn+86 18702135336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026